Suction Purpura Test and Treatment
The suction (capillary-fragility) test is not a standard diagnostic procedure for immune thrombocytopenic purpura (ITP) or other purpuric conditions, and treatment decisions should be based on platelet count, bleeding severity, and clinical presentation rather than capillary fragility testing.
Understanding the Suction/Capillary Fragility Test
The capillary fragility test (also called Rumpel-Leede test or tourniquet test) historically involved applying negative pressure or a blood pressure cuff to assess vascular integrity. While older research examined this in diabetic patients and elderly populations 1, 2, this test is not recommended in modern guidelines for diagnosing or managing purpura.
Why This Test Is Not Used
- Not mentioned in major ITP guidelines: The comprehensive ASH guidelines from 1996 and 2011 3, 4 make no reference to capillary fragility testing as part of diagnostic workup
- Diagnosis relies on different criteria: ITP diagnosis is based on history, physical examination, complete blood count, and peripheral smear examination—not capillary fragility 3, 4
- No treatment implications: Management decisions are driven by platelet counts and bleeding symptoms, not capillary fragility results
Actual Diagnostic Approach for Purpura
Key Clinical Assessment Points
When evaluating purpura, focus on:
History elements 3:
- Type and severity of bleeding (petechiae vs. ecchymosis vs. mucosal bleeding)
- Duration of symptoms
- Medication history (especially antiplatelet agents, heparin, quinidine)
- HIV risk factors
- Family history of bleeding disorders
- Prior hemostasis with surgeries or pregnancies
Physical examination 3:
- Distribution and type of purpuric lesions
- Presence of hepatosplenomegaly or lymphadenopathy (suggests alternative diagnosis)
- Signs of systemic disease or infection
- Neurologic examination (baseline for potential CNS bleeding)
Laboratory Workup
- Complete blood count with platelet count
- Peripheral blood smear examination
- PT/INR and aPTT if coagulopathy suspected
Additional testing when indicated 5:
- Platelet function testing if drug-induced dysfunction suspected
- HIV testing if risk factors present
- Blood pressure and liver function tests in pregnant women
Treatment Based on Platelet Count and Bleeding
Adults with ITP
Platelet count <10,000 3:
- Treatment required regardless of symptoms
- Options: High-dose glucocorticoids (prednisone 1-2 mg/kg/day) or IVIg
Platelet count 10,000-30,000 3:
- Treat if significant mucous membrane bleeding present
- Observation acceptable if asymptomatic
Platelet count 30,000-50,000 3:
- Treat only if clinically important bleeding present
- Observation appropriate for asymptomatic patients
Platelet count >50,000 3:
- Routine treatment not indicated
- Glucocorticoids and IVIg inappropriate as routine therapy
Severe Life-Threatening Bleeding (Any Platelet Count)
Immediate multimodal therapy 3:
- High-dose parenteral glucocorticoids (methylprednisolone 30 mg/kg/day)
- IVIg
- Platelet transfusions
- Hospitalization with critical care measures
Pregnant Women with ITP
Platelet count >50,000 3:
- No routine treatment required
- Sufficient for vaginal delivery or cesarean section
Platelet count <10,000 3:
- Treatment required
- IVIg appropriate in third trimester
Platelet count 10,000-30,000 3:
- Treat if in second/third trimester AND bleeding
Perioperative Management
Surgical patients 5:
- Platelet transfusion rarely indicated if count >100 × 10⁹/L
- Usually indicated if count <50 × 10⁹/L with excessive bleeding
- Visual assessment of surgical field for microvascular bleeding essential
- Procedures with limited blood loss may proceed with counts <50 × 10⁹/L
Common Pitfalls to Avoid
- Do not order capillary fragility tests for ITP diagnosis or management—they provide no actionable information
- Do not treat based on platelet count alone in stable patients with counts >30,000 without bleeding
- Do not use platelet transfusions prophylactically in ITP patients with increased platelet destruction (heparin-induced thrombocytopenia, ITP, TTP) 5
- Do not delay treatment in patients with platelet counts <20,000 and significant mucous membrane bleeding 3
- Do not perform bone marrow examination routinely in children and adolescents with typical ITP features 4